36041414|t|Intranasal Insulin Attenuates the Long-Term Adverse Effects of Neonatal Hyperglycemia on the Hippocampus in Rats.
36041414|a|Hyperglycemia due to relative hypoinsulinism is common in extremely preterm infants and is associated with hippocampus-mediated long-term cognitive impairment. In neonatal rats, hypoinsulinemic hyperglycemia leads to oxidative stress, altered neurochemistry, microgliosis, and abnormal synaptogenesis in the hippocampus. Intranasal insulin (INS) bypasses the blood-brain barrier, targets the brain, and improves synaptogenesis in rodent models, and memory in adult humans with Alzheimer's disease or type 2 diabetes, without altering the blood levels of insulin or glucose. To test whether INS improves hippocampal development in neonatal hyperglycemia, rat pups were subjected to hypoinsulinemic hyperglycemia by injecting streptozotocin (STZ) at a dose of 80 mg/kg i.p. on postnatal day (P) 2 and randomized to INS, 0.3U twice daily from P3-P6 (STZ + INS group), or no treatment (STZ group). The acute effects on hippocampal neurochemical profile and transcript mRNA expression of insulin receptor (Insr), glucose transporters (Glut1, Glut4, and Glut8), and poly(ADP-ribose) polymerase-1 (Parp1, a marker of oxidative stress) were determined on P7 using in vivo 1H MR spectroscopy (MRS) and qPCR. The long-term effects on the neurochemical profile, microgliosis, and synaptogenesis were determined at adulthood using 1H MRS and histochemical analysis. Relative to the control (CONT) group, mean blood glucose concentration was higher from P3 to P6 in the STZ and STZ + INS groups. On P7, MRS showed 10% higher taurine concentration in both STZ groups. qPCR showed 3-folds higher Insr and 5-folds higher Glut8 expression in the two STZ groups. Parp1 expression was 18% higher in the STZ group and normal in the STZ + INS group. At adulthood, blood glucose concentration in the fed state was higher in the STZ and STZ + INS groups. MRS showed 59% higher brain glucose concentration and histochemistry showed microgliosis in the hippocampal subareas in the STZ group. Brain glucose was normal in the STZ + INS group. Compared with the STZ group, phosphocreatine and phosphocreatine/creatine ratio were higher, and microglia in the hippocampal subareas fewer in the STZ + INS group (p < 0.05 for all). Neonatal hyperglycemia was associated with abnormal glucose metabolism and microgliosis in the adult hippocampus. INS administration during hyperglycemia attenuated these adverse effects and improved energy metabolism in the hippocampus.
36041414	11	18	Insulin	Chemical	MESH:D007328
36041414	63	85	Neonatal Hyperglycemia	Disease	MESH:D006943
36041414	108	112	Rats	Species	10116
36041414	114	127	Hyperglycemia	Disease	MESH:D006943
36041414	144	158	hypoinsulinism	Disease	
36041414	252	272	cognitive impairment	Disease	MESH:D003072
36041414	286	290	rats	Species	10116
36041414	292	321	hypoinsulinemic hyperglycemia	Disease	MESH:D006943
36041414	373	385	microgliosis	Disease	
36041414	579	585	humans	Species	9606
36041414	591	610	Alzheimer's disease	Disease	MESH:D000544
36041414	614	629	type 2 diabetes	Disease	MESH:D003924
36041414	679	686	glucose	Chemical	MESH:D005947
36041414	744	766	neonatal hyperglycemia	Disease	MESH:D006943
36041414	768	771	rat	Species	10116
36041414	795	824	hypoinsulinemic hyperglycemia	Disease	MESH:D006943
36041414	838	852	streptozotocin	Chemical	MESH:D013311
36041414	854	857	STZ	Chemical	MESH:D013311
36041414	961	964	STZ	Chemical	MESH:D013311
36041414	996	999	STZ	Chemical	MESH:D013311
36041414	1097	1113	insulin receptor	Gene	24954
36041414	1115	1119	Insr	Gene	24954
36041414	1144	1149	Glut1	Gene	24778
36041414	1151	1156	Glut4	Gene	25139
36041414	1162	1167	Glut8	Gene	85256
36041414	1174	1203	poly(ADP-ribose) polymerase-1	Gene	25591
36041414	1205	1210	Parp1	Gene	25591
36041414	1278	1280	1H	Chemical	-
36041414	1365	1377	microgliosis	Disease	
36041414	1433	1435	1H	Chemical	-
36041414	1511	1524	blood glucose	Chemical	MESH:D001786
36041414	1571	1574	STZ	Chemical	MESH:D013311
36041414	1579	1582	STZ	Chemical	MESH:D013311
36041414	1626	1633	taurine	Chemical	MESH:D013654
36041414	1656	1659	STZ	Chemical	MESH:D013311
36041414	1695	1699	Insr	Gene	24954
36041414	1719	1724	Glut8	Gene	85256
36041414	1747	1750	STZ	Chemical	MESH:D013311
36041414	1759	1764	Parp1	Gene	25591
36041414	1798	1801	STZ	Chemical	MESH:D013311
36041414	1826	1829	STZ	Chemical	MESH:D013311
36041414	1832	1835	INS	CellLine	CVCL:XA15
36041414	1857	1870	blood glucose	Chemical	MESH:D001786
36041414	1920	1923	STZ	Chemical	MESH:D013311
36041414	1928	1931	STZ	Chemical	MESH:D013311
36041414	1974	1981	glucose	Chemical	MESH:D005947
36041414	2022	2034	microgliosis	Disease	
36041414	2070	2073	STZ	Chemical	MESH:D013311
36041414	2087	2094	glucose	Chemical	MESH:D005947
36041414	2113	2116	STZ	Chemical	MESH:D013311
36041414	2148	2151	STZ	Chemical	MESH:D013311
36041414	2159	2174	phosphocreatine	Chemical	MESH:D010725
36041414	2179	2194	phosphocreatine	Chemical	MESH:D010725
36041414	2195	2203	creatine	Chemical	MESH:D003401
36041414	2278	2281	STZ	Chemical	MESH:D013311
36041414	2314	2336	Neonatal hyperglycemia	Disease	MESH:D006943
36041414	2357	2384	abnormal glucose metabolism	Disease	MESH:D044882
36041414	2389	2401	microgliosis	Disease	
36041414	2454	2467	hyperglycemia	Disease	MESH:D006943
36041414	Negative_Correlation	MESH:D007328	MESH:D006943
36041414	Association	MESH:D013311	85256
36041414	Positive_Correlation	MESH:D001786	MESH:D013311
36041414	Positive_Correlation	MESH:D013311	MESH:D006943
36041414	Positive_Correlation	MESH:D013311	MESH:D013654
36041414	Association	MESH:D013311	24954
36041414	Positive_Correlation	MESH:D013311	25591

